MedPath
FDA Approval

Lysodren

January 19, 2024

HUMAN PRESCRIPTION DRUG LABEL

mitotane(500 mg in 1 1)
Mitotane(500 mg in 1 1)

Manufacturing Establishments (3)

ISP Chemicals LLC

HRA Pharma Rare Diseases

078413681

Corden Pharma Latina S.p.A.

HRA Pharma Rare Diseases

339062883

Latina Pharma S.p.A.

HRA Pharma Rare Diseases

339062883

Products (1)

Lysodren

76336-080

NDA016885

NDA (C73594)

ORAL

January 19, 2024

mitotaneActive
Code: 78E4J5IB5JClass: ACTIBQuantity: 500 mg in 1 1
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
polyethylene glycol 3350Inactive
Code: G2M7P15E5PClass: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4Class: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
MitotaneActive
Code: 78E4J5IB5JClass: ACTIBQuantity: 500 mg in 1 1
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5PClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
© Copyright 2025. All Rights Reserved by MedPath